T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Air Products & Chemicals
APD
$67.7B
| $469M | 0.06% |
1,950,932
+39,169
| +2% | +$9.52M |
|
302
PTC
PTC
$16.1B
| $469M | 0.06% |
4,406,339
-67,741
| -2% | -$7.31M |
|
303
Cable One
CABO
$191M
| $465M | 0.06% |
360,940
-307,054
| -46% | -$391M |
|
304
CubeSmart
CUBE
$9.28B
| $465M | 0.06% |
10,889,600
+1,489,916
| +16% | +$68.6M |
|
305
Littelfuse
LFUS
$11.7B
| $465M | 0.06% |
1,830,345
-44,108
| -2% | -$11.1M |
|
306
Magnolia Oil & Gas
MGY
$6.25B
| $462M | 0.06% |
22,028,899
+62,560
| +0.3% | +$1.56M |
|
307
Corteva
CTVA
$50.4B
| $461M | 0.06% |
8,516,321
-1,692,775
| -17% | -$98.3M |
|
|
SRCL
308
DELISTED
Stericycle Inc
SRCL
| $459M | 0.06% |
10,470,754
-927,303
| -8% | -$46M |
|
309
EastGroup Properties
EGP
$10.9B
| $458M | 0.06% |
2,964,584
+217,183
| +8% | +$38.1M |
|
310
Amgen
AMGN
$225B
| $456M | 0.06% |
1,874,293
-788,648
| -30% | -$193M |
|
311
Carvana
CVNA
$79.7B
| $454M | 0.06% |
100,504,215
+33,354,965
| +50% | +$351M |
|
312
Flowers Foods
FLO
$1.52B
| $447M | 0.06% |
16,980,686
-4,365,393
| -20% | -$115M |
|
313
ICU Medical
ICUI
$4.48B
| $445M | 0.06% |
2,709,115
+1,274
| +0% | +$245K |
|
|
SGEN
314
DELISTED
Seagen Inc. Common Stock
SGEN
| $445M | 0.06% |
2,514,889
-2,336,066
| -48% | -$337M |
|
315
FirstEnergy
FE
$27.2B
| $444M | 0.06% |
11,561,948
-4,932,658
| -30% | -$211M |
|
|
P
316
Everpure Inc
P
$37B
| $440M | 0.06% |
17,099,816
-1,221,944
| -7% | -$33.8M |
|
317
Motorola Solutions
MSI
$77.7B
| $439M | 0.06% |
2,096,526
-1,138,650
| -35% | -$248M |
|
318
Doximity
DOCS
$4.45B
| $437M | 0.06% |
12,545,173
-126,114
| -1% | -$4.97M |
|
319
TechnipFMC
FTI
$29.5B
| $436M | 0.06% |
64,762,957
+4,293,102
| +7% | +$32.7M |
|
320
Magna International
MGA
$18.6B
| $436M | 0.06% |
7,936,862
-1,710,402
| -18% | -$104M |
|
321
Elanco Animal Health
ELAN
$11.1B
| $435M | 0.06% |
22,158,248
-12,354,858
| -36% | -$292M |
|
322
Floor & Decor
FND
$6.32B
| $433M | 0.05% |
6,870,442
+6,042,378
| +730% | +$455M |
|
323
Clarivate
CLVT
$1.19B
| $428M | 0.05% |
30,885,031
+24,948
| +0.1% | +$373K |
|
324
BWX Technologies
BWXT
$15.8B
| $428M | 0.05% |
7,765,380
-947,325
| -11% | -$49.3M |
|
325
Boston Beer
SAM
$1.89B
| $421M | 0.05% |
1,388,870
-12,927
| -0.9% | -$4.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.